-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Sernova Biotherapeutics, Lowers Price Target to C$1

Benzinga·09/08/2026 17:14:56
语音播报
HC Wainwright & Co. analyst Joseph Pantginis maintains Sernova Biotherapeutics (TSX:SVA) with a Buy and lowers the price target from C$6 to C$1.